Supporting the implementation of personalised medicine in the Danish healthcare system
The Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care through the use of genomics. Their partner at Princess Margaret Cancer Centre, relies on OICR and whole-genome and transcriptome data to guide treatment and monitor disease progression as part of clinical trials. At the core of this, is the sequencing performed on the NovaSeq™ X Plus. Learn how OICR is using the NovaSeq™ X Plus to accelerate projects, like those with Dr. Stephanie Lheureux at Princess Margaret. The economics, speed, and throughput are ultimately aiding both institutions in reaching their organizational goals and missions. Change the world with the NovaSeq X Series: https://lnkd.in/dVvXHDA3 https://lnkd.in/djDsrtkJ
